These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24313854)

  • 1. Increased soluble C5b-9 in CSF of neuromyelitis optica.
    Wang H; Wang K; Wang C; Qiu W; Lu Z; Hu X
    Scand J Immunol; 2014 Feb; 79(2):127-30. PubMed ID: 24313854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
    Kuroda H; Fujihara K; Takano R; Takai Y; Takahashi T; Misu T; Nakashima I; Sato S; Itoyama Y; Aoki M
    J Neuroimmunol; 2013 Jan; 254(1-2):178-82. PubMed ID: 23017732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
    Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K
    Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
    Veszeli N; Füst G; Csuka D; Trauninger A; Bors L; Rozsa C; Nagy Z; Jobbágy Z; Eizler K; Prohászka Z; Varga L; Illes Z
    Mol Immunol; 2014 Feb; 57(2):200-9. PubMed ID: 24172223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
    Zhong X; Wang H; Dai Y; Wu A; Bao J; Xu W; Cheng C; Lu Z; Qiu W; Hu X
    J Neuroimmunol; 2011 Dec; 240-241():104-8. PubMed ID: 22036953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
    Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
    Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
    Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
    Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
    Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
    Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
    Wang H; Wang K; Xu W; Wang C; Qiu W; Zhong X; Dai Y; Wu A; Hu X
    J Neurochem; 2012 Jul; 122(1):19-23. PubMed ID: 22469018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD.
    Kaneko K; Kuroda H; Matsumoto Y; Sakamoto N; Yamazaki N; Yamamoto N; Umezawa S; Namatame C; Ono H; Takai Y; Takahashi T; Fujimori J; Nakashima I; Harigaya Y; Lassmann H; Fujihara K; Misu T; Aoki M
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200293. PubMed ID: 39133885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation in patients with neuromyelitis optica.
    Nytrova P; Potlukova E; Kemlink D; Woodhall M; Horakova D; Waters P; Havrdova E; Zivorova D; Vincent A; Trendelenburg M
    J Neuroimmunol; 2014 Sep; 274(1-2):185-91. PubMed ID: 25109258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
    Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
    Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
    Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X
    Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
    Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X
    Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
    Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.
    Wu A; Zhong X; Wang H; Xu W; Cheng C; Dai Y; Bao J; Qiu W; Lu Z; Hu X
    Can J Neurol Sci; 2012 Nov; 39(6):813-20. PubMed ID: 23041403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
    Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
    Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced complement consumption in neuromyelitis optica and Behçet's disease patients.
    Tüzün E; Kürtüncü M; Türkoğlu R; Içöz S; Pehlivan M; Birişik O; Eraksoy M; Akman-Demir G
    J Neuroimmunol; 2011 Apr; 233(1-2):211-5. PubMed ID: 21215465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.